-
CSR Summary Not Yet Available
-
NCT01173562
-
Primary Citation
-
Data Specification Not Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameMebendazoleProduct NameVERMOXTherapeutic AreaParasitic DiseasesEnrollment396% Female48%% White1%
Product ClassAntiparasiticsSponsor Protocol NumberMEBENDAZOLGAI3002Data PartnerJohnson & JohnsonCondition StudiedHealthy VolunteersMean/Median Age (Years)4.6
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available